Edelmann, J., & Zenz, T. (2014). High resolution genomic profiling of primary "Ultra high risk" and refractory chronic lymphocytic leukemia: Results from the CLL2O trial. Blood, 124(21), .
Chicago-Zitierstil (17. Ausg.)Edelmann, Jennifer, und Thorsten Zenz. "High Resolution Genomic Profiling of Primary "Ultra High Risk" and Refractory Chronic Lymphocytic Leukemia: Results from the CLL2O Trial." Blood 124, no. 21 (2014).
MLA-Zitierstil (9. Ausg.)Edelmann, Jennifer, und Thorsten Zenz. "High Resolution Genomic Profiling of Primary "Ultra High Risk" and Refractory Chronic Lymphocytic Leukemia: Results from the CLL2O Trial." Blood, vol. 124, no. 21, 2014.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.